Athanor Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,565
| Closed | -$261K | – | 772 |
|
|
2020
Q4 | $261K | Sell |
4,565
-2,152
| -32% | -$123K | 0.01% | 551 |
|
|
2020
Q3 | $203K | Sell |
6,717
-3,187
| -32% | -$96.3K | 0.01% | 471 |
|
|
2020
Q2 | $323K | Buy |
+9,904
| New | +$323K | 0.02% | 383 |
|
|
2020
Q1 | – | Sell |
-16,300
| Closed | -$499K | – | 155 |
|
|
2019
Q4 | $499K | Sell |
16,300
-8,200
| -33% | -$251K | 0.02% | 209 |
|
|
2019
Q3 | $590K | Buy |
24,500
+9,300
| +61% | +$224K | 0.04% | 130 |
|
|
2019
Q2 | $385K | Buy |
+15,200
| New | +$385K | 0.05% | 95 |
|